Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- CASCADEIndependent statistical analysis of Central Venous Access Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03480542).
- CASDAF-HDIndependent statistical analysis of Characterising the Stable and Dynamic Left Atrial Substrate in Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Case Managers for CVD Risk Reduction in HIV Clinic: Complete Statistical AnalysisIndependent statistical analysis of Case Managers for CVD Risk Reduction in HIV Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03839394).
- CASEIIIndependent statistical analysis of Cytosponge Adequacy Study Evaluation II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02395471).
- CASPIANIndependent statistical analysis of CASPIAN, the randomized phase 3 trial of durvalumab with platinum-based chemotherapy in untreated extensive-stage small cell lung cancer, including overall survival, progression-free survival, response, statistical methodology, and interpretation.
- CassetteIndependent statistical analysis of Correlation of Auscultatory Severity of Aortic Stenosis With Trans Thoracic Echocardiography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CASSIOPEIAA complete statistical analysis of the phase 3 CASSIOPEIA trial evaluating daratumumab in transplant-eligible participants with previously untreated multiple myeloma, including trial design, primary endpoints, reported statistical analyses, safety, and interpretation.
- CASTIndependent statistical analysis of Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00767039).
- CATALYSTIndependent statistical analysis of A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CATCH-UPIndependent statistical analysis of Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Catheter Placement for Hepatic Hydrothorax: Complete Statistical AnalysisIndependent statistical analysis of Catheter Placement for Hepatic Hydrothorax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02595567).
- Causes of Rotavirus Vaccine Failure in Zambian Children: Complete Statistical AnalysisIndependent statistical analysis of Causes of Rotavirus Vaccine Failure in Zambian Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01886833).
- Caverject User Study: Complete Statistical AnalysisIndependent statistical analysis of Caverject User Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01008605).
- CBIndependent statistical analysis of Cutting Balloon Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01205568).
- CBDIndependent statistical analysis of Cannabidiol Treatment in Patients With Early Psychosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02504151).
- CBDIPPCFSIPIndependent statistical analysis of Comparison Between Dexamethasone and Ibuprofen on Pain Prevention and Control Following Surgical Implant Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CBGJ398XUS04Independent statistical analysis of BGJ398 for Patients With Tumors With FGFR Genetic Alterations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02160041).
- CBT-AIndependent statistical analysis of Group CBT for Aggression in Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02233517).
- CBTi GWIIndependent statistical analysis of Cognitive Behavioral Therapy for Insomnia for Gulf War Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02782780).
- CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas: Complete Statistical AnalysisIndependent statistical analysis of CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00540579).
- CC-5013 (Lenalidomide) and Rituximab in Waldenstrom’s Macroglobulinemia: Complete Statistical AnalysisIndependent statistical analysis of CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142168).
- CCBCRISIS04Independent statistical analysis of Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CCCIndependent statistical analysis of The ConnectedCancerCare Pilot Study (CCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03618017).
- CCIIndependent statistical analysis of Bilateral; Flank Study With Crown Cooling Insert: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02554760).
- CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements: Complete Statistical AnalysisIndependent statistical analysis of CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR: Complete Statistical AnalysisIndependent statistical analysis of CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR: primary endpoint results, effect estimate with confidence interval,…
- CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- CDI-SCOPEIndependent statistical analysis of A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection: primary endpoint results, effect estimate with…
- CDP-Choline and Working Memory After TBI: A Neuroimaging Study: Complete Statistical AnalysisIndependent statistical analysis of CDP-Choline and Working Memory After TBI: A Neuroimaging Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00727246).
- CEASeIndependent statistical analysis of Clinical Evaluation of Ajust™ in Stress Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01290796).
- CECSIDIndependent statistical analysis of Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting: Complete Statistical AnalysisIndependent statistical analysis of Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835354).
- Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery: Complete Statistical AnalysisIndependent statistical analysis of Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CELESTIALIndependent statistical analysis of the phase 3 CELESTIAL trial of cabozantinib versus placebo in hepatocellular carcinoma after prior sorafenib, including overall survival, progression-free survival, objective response, trial design, and statistical methodology.
- Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC: Complete Statistical AnalysisIndependent statistical analysis of Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04242173).
- CENTAURIndependent statistical analysis of Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CERAIndependent statistical analysis of Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment: Complete Statistical AnalysisIndependent statistical analysis of Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02901574).
- Cerebral Blood Flow During Propofol Anaesthesia: Complete Statistical AnalysisIndependent statistical analysis of Cerebral Blood Flow During Propofol Anaesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02951273).
- Cerebral Protection in Transcatheter Aortic Valve Replacement: Complete Statistical AnalysisIndependent statistical analysis of Cerebral Protection in Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02214277).
- Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children: Complete Statistical AnalysisIndependent statistical analysis of Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00991185).
- Cerebrotendinous Xanthomatosis (CTX) Prevalence Study: Complete Statistical AnalysisIndependent statistical analysis of Cerebrotendinous Xanthomatosis (CTX) Prevalence Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02638220).
- CERPIndependent statistical analysis of RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the…
- CERTAIN-2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection: primary endpoint results, effect estimate with confidence…
- Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis: Complete Statistical AnalysisIndependent statistical analysis of Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01087762).
- Cervical Cancer Prevention for Black Adults: Complete Statistical AnalysisIndependent statistical analysis of Cervical Cancer Prevention for Black Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04927494).
- Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix: Complete Statistical AnalysisIndependent statistical analysis of Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon: Complete Statistical AnalysisIndependent statistical analysis of Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cervical Ripening in Premature Rupture of Membranes: Complete Statistical AnalysisIndependent statistical analysis of Cervical Ripening in Premature Rupture of Membranes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02314728).